[notice] 2 Planning Commission “on the issue of clinical laboratory project management”:

In March 3rd, the national health and Family Planning Commission website issued “notice on issues related to clinical laboratory project management”. Stated in the notice:

The country should further implement the “measures” clinical laboratory management of medical institutions, to strengthen the construction and management of clinical laboratory. The medical institutions should strengthen the internal quality control of clinical laboratory, health administrative departments to organize the work of clinical laboratory quality assessment, to ensure the accuracy and reliability of test results.

The medical institutions should establish and improve the clinical inspection system project management, strengthen project management of clinical laboratory. Not included in the “medical institutions for clinical laboratory project directory (2013 Edition)”, but the clinical significance is clear, specific and sensitive, good price and reasonable benefits of clinical tests, should be timely demonstration, meet the clinical needs.

The medical institutions in the introduction of a new clinical examination in the course of the project, a reasonable set of audit procedures, optimize processes, improve efficiency, to meet the clinical needs of the test items are used in a timely manner.

This notice, interpreted as the industry planning commission to test clinical laboratory (LDT) release”. But LDT’s benign development also need to guard planning, CFDA, medical insurance bureau, price bureau and other aspects to improve.

[3] national “13th Five-Year” planning completed, accurate medical included:

Xinhua news agency is authorized to publish “the People’s Republic of China March 17th National Economic and social development of the thirteenth five year plan”, a total of more than 65600 words, the thesis consists of eighty chapters. In the twenty-third chapter, planning to support the development of strategic emerging industries, biotechnology, medical precision among.

[4] Hubei province pricing NIPT, the fee is 1460 yuan / times:

In the Hubei Provincial Price Bureau, the provincial health and Family Planning Commission jointly issued the “on the fetal chromosomal aneuploidy detection gene project price related issues notice”, defined the inspection fees for 1460 yuan / times, the detection cost is greatly reduced compared with the previous. The meeting also officially launched the implementation of the poverty-stricken areas of neonatal free deafness gene screening”.